Nektar Therapeutics (NKTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 222,261 | 911,125 | 34,805 | 4,762 | 37,967 |
| Marketable Securities | 1,198,149 | 912,683 | 261,854 | 291,370 | 314,600 |
| Receivables | 31,937 | 35,315 | 15,607 | 5,014 | 3,314 |
| Inventories | 13,296 | 11,884 | 10,675 | 10,726 | 13,654 |
| Other current assets | 39,539 | 34,940 | 13,074 | 14,948 | 13,260 |
| TOTAL | $1,505,182 | $1,905,947 | $336,015 | $326,820 | $382,795 |
| Non-Current Assets | |||||
| PPE Net | 44,881 | 45,000 | 46,328 | 47,463 | 62,396 |
| Investments And Advances | 619,140 | 282,277 | 37,157 | 57,088 | 59,596 |
| Intangibles | 76,501 | 76,501 | 76,501 | 76,501 | 76,501 |
| Other Non-Current Assets | 3,394 | 3,362 | 789 | 994 | 767 |
| TOTAL | $743,916 | $407,140 | $160,775 | $182,046 | $199,260 |
| Total Assets | $2,249,098 | $2,313,087 | $496,790 | $508,866 | $582,055 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,494 | 10,674 | 11,375 | 4,782 | 8,563 |
| Accrued Expenses | 54,086 | 43,152 | 39,010 | 25,767 | 30,286 |
| Other current liabilities | 6,610 | 10,090 | 105 | 446 | 16,420 |
| TOTAL | $108,083 | $96,897 | $80,697 | $56,163 | $92,544 |
| Non-Current Liabilities | |||||
| Long Term Debt | 246,514 | 246,078 | 245,643 | 245,207 | 244,771 |
| Deferred Revenues | 15,676 | 17,988 | 19,531 | 18,949 | 25,491 |
| Other Non-Current Liabilities | 92,969 | 95,918 | 99,359 | 100,647 | 104,353 |
| TOTAL | $350,893 | $355,776 | $357,810 | $364,875 | $405,349 |
| Total Liabilities | $458,976 | $452,673 | $438,507 | $421,038 | $497,893 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,545 | 11,504 | 11,433 | 10,734 | 10,503 |
| Common Shares | 17 | 17 | 16 | 15 | 15 |
| Retained earnings | -1,325,839 | -1,229,696 | -2,201,156 | -2,117,941 | -2,084,115 |
| Other shareholders' equity | -5,378 | -4,002 | -2,796 | -2,111 | -1,907 |
| TOTAL | $1,790,122 | $1,860,414 | $58,283 | $87,828 | $84,162 |
| Total Liabilities And Equity | $2,249,098 | $2,313,087 | $496,790 | $508,866 | $582,055 |